Cornea

A look back on what's happened in optometry during the week of Jan. 7-Jan. 12, 2023.

Two novel, dropless technologies for keratoconus and dry eye disease make major advances with more to come later in 2023.

A recent study showed herpesvirus DNA in a high percentage of corneal grafts after transplantation.

Over the years, IKA has become an invaluable resource for eye care professionals.

In the second deal between Harrow and Novartis, the former is expected to add 5 ophthalmic products to its portfolio.

Justin Schweitzer, OD, gives a brief overview of his EyeCon 2022 presentations, reflecting on pipeline advancements made in optometry in 2022.

The FDA granted orphan drug designation to BRM424 (BRIM Biotechnology) to treat neurotrophic keratitis (NK).

Stephanie Woo, OD, FAAO, FSLS, and S. Barry Eiden, OD, FAAO, discuss the Keratoconus Essentials Program, a joint effort between Woo University and the International Keratoconus Academy.

Rob Sambursky, MD, president of Verséa Ophthalmics, sat down with David Hutton of Ophthalmology Times to discuss 3 major developments in the company pipeline.

Successful outcomes demand both corneal and contact lens expertise.

Chris Kenrick, OD, shares what she finds to be most important from her discussion this year at AAOpt 2022.

Intact corneal tissue can be reused for preservation and reimplantation.

Graham Erickson, OD, shares highlights from his AAOpt 2022 presentation, "Optimizing visual performance for sports."

Christina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.

Presbyopia-correcting drops for patients with low, up-close visual function.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.

In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.

When considering the best modality these lenses' stability are superior.

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, shares highlights from his Vision Expo West presentation: "Corneal diagnostics: A-Z."

Marc Bloomenstein, OD, FAAO, shares key takeaways from his VEW 2022 presentation, "Corneal relationship therapy: managing the neurotrophic keratitis."

Japanese researchers conducted a systematic review that identified clinical features and host factors associated with corneal allograft rejection after COVID-19 vaccination.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part four.

Consider 4 conditions when treating this patient population.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Knowing your glaucoma vitals is key to providing best treatment for patients.

Early diagnosis enables cross-linking treatment before significant vision loss.

Build a stronger practice, generate revenue, and help patients avoid vision loss